Literature DB >> 26280379

Cognitive and Functional Correlates of NPI-Q Scores and Symptom Clusters in Mildly Demented Alzheimer Patients.

Jennifer N Travis Seidl1, Paul J Massman.   

Abstract

Previous research has demonstrated an association between the emotional and behavioral symptoms of dementia, known as neuropsychiatric symptoms, and cognitive and functional decline among patients with Alzheimer disease (AD). The present study aimed to identify associations between neuropsychiatric symptoms as measured by the Neuropsychiatric Inventory-Questionnaire (NPI-Q) and cognitive and functional performance. Participants were 256 AD patients enrolled in the Alzheimer's Disease and Memory Disorders Center at Baylor College of Medicine. An exploratory factor analysis of the NPI-Q indicated a 2-factor structure consisting of Negative/Oppositional and Anxiety/Restlessness factors. Regression analyses revealed significant associations between greater total severity of neuropsychiatric symptoms and poorer performance on basic and Instrumental Activities of Daily Living. Greater severity of Anxiety/Restlessness symptoms was associated with poor performance on measures of visuospatial functioning and basic and instrumental activities of daily living. The Negative/Oppositional factor was not related to cognition or functioning. In summary, neuropsychiatric symptoms (particularly Anxiety/Restlessness symptoms) were related to cognition and everyday functioning. Proper assessment and treatment of these symptoms is essential for improving cognition and functioning in AD patients.

Entities:  

Mesh:

Year:  2016        PMID: 26280379     DOI: 10.1097/WAD.0000000000000104

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  7 in total

1.  Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-03-26       Impact factor: 4.669

2.  Effectiveness of "Reducing Disability in Alzheimer's Disease" Among Dyads With Moderate Dementia.

Authors:  Jaime Perales-Puchalt; Kelli Barton; Lauren Ptomey; Michelle Niedens; Amy Yeager; Laura Gilman; Pam Seymour; Amanda George; Susan Sprague; Antonio Mirás Neira; Rik Van Dyke; Linda Teri; Eric D Vidoni
Journal:  J Appl Gerontol       Date:  2020-07-01

3.  An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death.

Authors:  Jiayue Qiu; Felicia C Goldstein; John J Hanfelt
Journal:  Am J Geriatr Psychiatry       Date:  2022-01-03       Impact factor: 7.996

4.  Agitated behaviors among elderly people with dementia living in their home in Taiwan.

Authors:  Huei-Ling Huang; Yea-Ing L Shyu; Wen-Chuin Hsu
Journal:  Clin Interv Aging       Date:  2018-06-29       Impact factor: 4.458

5.  The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia.

Authors:  Antti Cajanus; Eino Solje; Juha Koikkalainen; Jyrki Lötjönen; Noora-Maria Suhonen; Ilona Hallikainen; Ritva Vanninen; Päivi Hartikainen; Matteo de Marco; Annalena Venneri; Hilkka Soininen; Anne M Remes; Anette Hall
Journal:  Front Neurol       Date:  2019-10-03       Impact factor: 4.003

6.  Is Barthel Index Suitable for Assessing Activities of Daily Living in Patients With Dementia?

Authors:  Yayan Yi; Lin Ding; Huangliang Wen; Jialan Wu; Kiyoko Makimoto; Xiaoyan Liao
Journal:  Front Psychiatry       Date:  2020-05-08       Impact factor: 4.157

7.  Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.

Authors:  Willem S Eikelboom; Esther van den Berg; Ellen H Singleton; Sara J Baart; Michiel Coesmans; Annebet E Leeuwis; Charlotte E Teunissen; Bart N M van Berckel; Yolande A L Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele; Janne M Papma
Journal:  Neurology       Date:  2021-08-19       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.